Name: Xin Weisheng
Address: 5995 Huyi Road, Shanghai, AB 123C, China
Telephone: 021 5958 5480
Price range: Competitive

12 Jul 2023

Upperton Completes £15M GMP Manufacturing Facility

Upperton Pharma Solutions, a CDMO, has completed construction of its development and GMP manufacturing headquarters in Nottingham, UK.Located less than two miles from Upperton’s current headquarters,
Find out more
03 Jul 2023

Merck KGaA forks out $76m to expand reagent production in China

Germany’s Merck said the investment in Nantong, China will add manufacturing capacity to provide customers with reagents for quality control and testing.MilliporeSigma, the life sciences division of M
Find out more
28 Jun 2023

Solving the Sequence-Variant Problem in Therapeutic Protein Manufacture

Today’s clinicians use recombinant therapeutic proteins, such as monoclonal antibodies, to treat many diseases, from autoimmune disorders to cancer and beyond. Nonetheless, sequence variants (SVs), wh
Find out more
23 Jun 2023

Andelyn Biosciences opens clinical-stage production facility

From participating in Moonshot for Unicorns to raise awareness for a girl's treatments, to fundraising for the Ronald McDonald house, Andelyn Biosciences seeks to help the community by advancing Colum
Find out more
16 Jun 2023

How can AI be best harnessed for pharmacovigilance data?

A GSK-funded paper on pharmacovigilance stated that the pharma industry needs to harness the properties of data to allow optimal use of AI, otherwise “we will fail to do all we can for patient safety”
Find out more
13 Jun 2023

Sanofi wants to become first pharma company ‘powered by AI at scale’

Sanofi is rolling out its artificial intelligence app, Plai, as it doubles down on its efforts to incorporate AI throughout its research and development activities.The app, developed in partnership wi
Find out more
06 Jun 2023

New AMR certification launched for antibiotic manufacturers

Following publication of the Antibiotic Manufacturing Standard in 2022 to help overcome AMR, antibiotic manufacturers can now verify their actions through a new certification.A new global Minimized Ri
Find out more
31 May 2023

Modular Bioprocessing Lines Help Biopharma Cut Costs

Modular manufacturing facilities—production lines built from interchangeable, prefabricated elements—are winning over some of the biggest drug firms Pfizer, Sanofi, and Novartis’ biosimilars Sandoz un
Find out more
24 May 2023

AbCellera draws $300M in government funding

Federal and provincial officials announced $300 million in funding today for the new $700 million biotech campus to be built by AbCellera (Nasdaq:ABCL) in Mount Pleasant.AbCellera has emerged as one o
Find out more

News